228
Views
10
CrossRef citations to date
0
Altmetric
Review

The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review

ORCID Icon, , , , & ORCID Icon
Pages 257-279 | Published online: 12 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yue Liao, Hao Wang, Ke Wang, Kai Zi, Yongchun Shen, Lei Chen, Tao Wang, Jun Chen & Fuqiang Wen. (2023) Efficacy and safety of tiotropium bromide inhalation in symptomatic patients with chronic obstructive pulmonary disease: A multicenter, prospective, and observational study. Expert Review of Respiratory Medicine 17:3, pages 237-245.
Read now

Articles from other publishers (9)

David P. Scieszka, Devon Garland, Russell Hunter, Guy Herbert, Selita Lucas, Yan Jin, Haiwei Gu, Matthew J. Campen & Judy L. Cannon. (2023) Multi-omic assessment shows dysregulation of pulmonary and systemic immunity to e-cigarette exposure. Respiratory Research 24:1.
Crossref
Huaye Gao, Jintong Li, Xiaoping Chen, Zhanguo Sun, Gang Cui, Minlu Cheng & Li Ding. (2022) Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects. Frontiers in Pharmacology 13.
Crossref
Hao Wei, Lei Wu, Yongliang Jia, Jian Shen, Yanyou Li, Peng Sun, Qiangmin Xie, Xiaoping Chen, Yicheng Xie, Yingshuo Wang & Ziming Zhao. (2022) Pharmacokinetics and Tissue Distribution of Nasal Spray of a Novel Muscarinic Receptor Blocker, 101BHG-D01, in Dogs and Rats. Current Drug Metabolism 23:13, pages 1080-1088.
Crossref
Mario Cazzola, Fulvio Braido, Luigino Calzetta, Maria Gabriella Matera, Alessio Piraino, Paola Rogliani & Nicola Scichilone. (2022) The 5T approach in asthma: Triple Therapy Targeting Treatable Traits. Respiratory Medicine 200, pages 106915.
Crossref
Luigino Calzetta, Elena Pistocchini, Beatrice Ludovica Ritondo, Francesco Cavalli, Francesca Camardelli & Paola Rogliani. (2022) Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models. Heliyon 8:6, pages e09760.
Crossref
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Francesca Camardelli, Mario Cazzola, Paola Rogliani & Alfredo Chetta. (2022) Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis. Cells 11:11, pages 1797.
Crossref
Miguel Ángel Martínez-García, Grace Oscullo, Alberto García-Ortega, Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2021) Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis. Drugs 82:1, pages 1-13.
Crossref
Lveli Wang, Chuang Xiao, Yaping Liang, Zhiying Weng & Weimin Yang. (2021) Research Advances in COPD Drugs and Novel Targets. Nano LIFE 11:03, pages 2140008.
Crossref
Klára Szalontai, Nikolett Gémes, József Furák, Tünde Varga, Patrícia Neuperger, József Á. Balog, László G. Puskás & Gábor J. Szebeni. (2021) Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer. Journal of Clinical Medicine 10:13, pages 2889.
Crossref